Strategic partnerships Nushama has active collaboration initiatives with Awakn Life Sciences for KARE protocol and Relationship Resources for a ketamine-assisted mindfulness retreat, signaling ongoing opportunities to co-market and cross-sell psychedelic-assisted therapies to broader patient pools.

Expansion signals Operates multiple clinics in New York City, Rockland County, and Miami, indicating scalable regional footprint with potential for partner-led site expansions, referral networks, or white-label service offerings in adjacent markets.

Clinical efficacy focus Emphasizes evidence-led psychedelic treatments for depression, anxiety, chronic pain, addiction, and trauma, suggesting sales angles around validated outcomes, payer conversations, and performance-based partnerships with health systems or employers.

Revenue potential Current revenue range of one to ten million positions Nushama as a mid-market player with room for growth through enterprise collaborations, subscription or membership models, and expanded service lines like ketamine infusions and Spravato.

Tech and marketing readiness Uses WordPress and modern marketing tech (Klaviyo, AMP, JSON-LD) along with security and analytics tools, indicating readiness for enhanced digital campaigns, lead nurturing, and scalable patient acquisition partnerships.